Related Experiment Video
Updated: Jun 14, 2025
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
Melanoma overdiagnosis: What do we know and what do we do?
Simon Clark1, Nikita Rosendahl2, Cliff Rosendahl3
1MBChB, FRCPA, Senior Lecturer, Faculty of Medicine, The University of Queensland, Brisbane, Qld; Distinguished Visiting Professor TUMS, Department of Dermatology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Australian Journal of General Practice
|September 3, 2024
Summary
Melanoma overdiagnosis, identifying non-lethal skin cancers, may paradoxically reduce melanoma deaths in Australia. Higher diagnosis rates correlate with fewer excess deaths, suggesting a potential survival benefit.
Area of Science:
- Dermatology
- Epidemiology
- Public Health
Background:
- Melanoma overdiagnosis involves identifying and treating skin cancers unlikely to cause harm.
- This phenomenon raises concerns about unnecessary medical interventions and healthcare costs.
Purpose of the Study:
- To investigate the causes and extent of melanoma overdiagnosis in Australia.
- To explore a potential benefit of overdiagnosis: reducing melanoma-related mortality.
Main Methods:
- Analysis of Australian Cancer Atlas data.
- Statistical correlation analysis between melanoma diagnostic rates and excess mortality.
Main Results:
- A significant inverse correlation (r=-0.5978, P<0.0001) was found between high melanoma diagnostic rates and reduced excess melanoma deaths in Australian geographical areas.
- This inverse correlation was the strongest observed among 20 cancer types in the Atlas.
Conclusions:
- Higher rates of melanoma diagnosis may be associated with a reduction in melanoma mortality.
- Further research is needed to determine if early diagnosis of life-threatening melanomas in high-diagnosis areas contributes to this survival benefit.
